I am a woman of reproductive age using a urinary fertility monitor; based on my estrone‑3‑glucuronide (E1G), luteinising hormone (LH) and pregnanediol‑glucuronide (PDG) trends showing an LH surge peaking at 45 IU on cycle day 13 and still elevated on day 14, did I ovulate, and if so on which day? When should I begin progesterone supplementation for possible luteal phase insufficiency, and until when is the oocyte viable? Will intercourse on the evening of cycle day 15 still be within the fertile window?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ovulation Timing and Fertility Window Assessment

Based on your LH surge peaking at 45 IU on cycle day 13, you ovulated approximately 24–36 hours later, placing ovulation on cycle day 14 (likely around midday to evening). 1, 2, 3

Evidence of Ovulation

Your hormone pattern strongly confirms ovulation occurred:

  • LH surge dynamics: Your LH peaked at 45 IU on CD13 (FMU) and remained elevated at 45 on CD14 (FMU), then declined to 27.9 by CD14 evening, demonstrating the characteristic post-surge decline that confirms ovulation has occurred. 1, 2

  • PDG (progesterone metabolite) rise: Your PDG increased from baseline 3.2 μg/mL (CD5) to 4.7 μg/mL on CD14, marking the beginning of the post-ovulatory rise. The progesterone rise from baseline always occurs after ovulation and is the most reliable confirmation marker. 2, 3

  • E1G (estrogen) pattern: Your E1G peaked at 288.2 ng/mL on CD13 then declined to 197.8 ng/mL on CD14, consistent with the pre-ovulatory estrogen surge that precedes ovulation by approximately 0.5–1 day. 3

  • Pelvic pressure at 5:50 PM on CD14: This symptom coinciding with the hormonal timeline and resolving within 2 hours is consistent with ovulation occurring during this window. 1

Oocyte Viability Window

The egg remains viable for approximately 12–24 hours after ovulation. 1

  • Since ovulation likely occurred on CD14 (midday to evening based on your pressure symptom at 5:50 PM), the oocyte viability window extends until approximately CD15 midday to evening. 1

  • Intercourse on CD15 evening (tonight at 9:30 PM) is at the very tail end of the fertile window and has significantly reduced conception probability compared to intercourse before ovulation. 4

  • Sperm can survive 3–5 days in fertile cervical mucus, but the egg's 12–24 hour lifespan is the limiting factor once ovulation has occurred. 4

Progesterone Supplementation Timing

Begin progesterone supplementation on cycle day 16–17 (3 days post-ovulation). 1

  • Starting progesterone 3 days after ovulation allows the corpus luteum to establish baseline progesterone production without pharmacologic interference. 1

  • Your PDG should continue rising over the next several days; monitoring PDG levels on CD17–21 can help assess luteal phase adequacy before starting supplementation. 5, 6

  • A sustained PDG level above 5 μg/mL (ideally 7 μg/mL or higher) during the implantation window (approximately CD21–24 in your cycle) indicates adequate luteal function. 5, 6

Critical Timing Summary

  • Ovulation occurred: CD14 (approximately midday to evening)
  • Fertile window closed: CD15 evening (tonight) is the absolute last opportunity, though probability is low
  • Start progesterone: CD16–17 (2–3 days from now)
  • Monitor PDG rise: Continue testing through CD17–21 to confirm adequate luteal phase before supplementation

Important Caveats

  • Your FSH variability (8.7 on CD5, 12.2 on CD7, 2.4 on CD9) is within normal range for early follicular phase fluctuations and does not indicate ovarian dysfunction. 1

  • If you do not achieve pregnancy this cycle, consider timing intercourse earlier in the fertile window (starting when E1G begins rising, typically CD9–11 in your pattern) to maximize conception probability. 4

  • The optimal intercourse pattern is every 1–2 days beginning when E1G rises until after the LH surge, not waiting until ovulation has already occurred. 4

References

Guideline

Ovulation Timing and Progesterone Supplementation Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Monitoring the menstrual cycle: Comparison of urinary and serum reproductive hormones referenced to true ovulation.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 2015

Guideline

Post-Contraception Amenorrhea Evaluation and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

Why did my reproductive endocrinologist advise intercourse a day after the urinary pregnanediol-3-glucuronide rise when I already had sex 2-3 days before ovulation and am taking 200 mg progesterone daily from cycle day 15?
My fertile window opened today on cycle day 11 with estrone‑3‑glucuronide (E1G) 38.3 ng/mL and pregnanediol‑glucuronide (PdG) 6.5 µg/mL; when will the luteinizing hormone (LH) surge occur?
I am on cycle day 14 with an LH peak of 45 IU, estrone‑3‑glucuronide peak, PDG rise to 4.7 µg/mL, and a brief pelvic pressure at 5:50 pm; did I ovulate, when did it occur, when should I start progesterone for luteal‑phase insufficiency, and how long is the oocyte viable after ovulation?
Does estrone (e1g) level increase 7-10 days post peak in the luteal phase in a female patient of reproductive age, and if so, how much does it rise above baseline levels?
Does a rise in estrone glucuronide (E1G) 12 days after the initial evening luteinizing hormone (LH) surge indicate early pregnancy in a female of reproductive age with a history of progesterone supplementation?
A woman with new sexual partner presents a few weeks after symptom onset with vaginal itching, discharge, papular lesions, and is using over‑the‑counter clotrimazole/hydrocortisone; what is the most appropriate next step in evaluation and management?
What is the recommended initiation, titration schedule, target dose, and monitoring parameters for aripiprazole (Abilify) in treating depressive episodes of bipolar I disorder in adults?
How can I tell if my vulvar/perianal bumps are HPV genital warts in a woman with a recent new sexual partner, vaginal itching, discharge, and ineffective clotrimazole/hydrocortisone treatment?
What is the recommended initial treatment for bipolar depression?
Is it normal for HPV genital warts to present unilaterally on the vulva or perianal area and be difficult to see but palpable?
What additional history, physical examination findings, and diagnostic investigations are needed to evaluate a patient with a 2‑3‑week onset of intermittent productive cough with blood‑streaked sputum after a viral upper respiratory infection, worsened in the mornings and by supine position, cold air, laughter, and post‑exercise, who denies fever, pleuritic pain, dyspnea at rest, tachycardia, leg swelling, smoking/vaping, has no personal history of asthma, eczema, or chronic respiratory disease, is not taking any medications, and has a family history of asthma in a younger sibling?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.